Company Filing History:
Years Active: 2000
Title: Gregory Zuccaro, Jr: Innovator in Lymph Node Staging Technology
Introduction
Gregory Zuccaro, Jr. is a notable inventor based in Westlake, OH (US). He has made significant contributions to the field of medical technology, particularly in the area of lymph node staging. His innovative approach utilizes advanced imaging techniques to improve the accuracy of cancer diagnoses.
Latest Patents
Zuccaro holds a patent for a "System and method for staging regional lymph nodes using quantitative" analysis. This invention focuses on automatically staging regional lymph nodes under the TNM classification system by employing textural analyses of endoscopic ultrasound images. The method determines the N stage for a lymph node by analyzing the texture organization of a region corresponding to the node on a digitized ultrasound image. Specifically, it calculates Haralick's difference entropy and correlation textural features, comparing them to predetermined reference values to predict whether the lymph node is benign or malignant. Additionally, the cross-sectional area of the node is assessed to aid in making an N staging determination. This invention is particularly applicable in staging esophageal lymph nodes for the diagnosis and treatment of esophageal carcinoma.
Career Highlights
Gregory Zuccaro, Jr. is affiliated with the Cleveland Clinic Foundation, where he continues to work on innovative medical technologies. His expertise in imaging and analysis has positioned him as a valuable contributor to advancements in cancer diagnostics.
Collaborations
Zuccaro has collaborated with notable colleagues, including Robert M Cothren and Alexandre Purper Brandao. Their combined efforts in research and development have furthered the impact of their work in the medical field.
Conclusion
Gregory Zuccaro, Jr. exemplifies the spirit of innovation in medical technology through his patent for lymph node staging. His work not only enhances diagnostic accuracy but also contributes to improved patient outcomes in cancer treatment.